Wyong Rugby Leagues kicks goal to help end melanoma
28 March 2017
Wyong Rugby Leagues kicks goal to help end melanoma Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
The club has generously donated $60,000 to Melanoma Institute Australia to enable purchase of a new slide stainer which is vital for monitoring individual patient responses to melanoma treatment. The new equipment will help ensure life-saving clinical decisions can be made, including switching therapies should resistance begin to develop.
CEO of Melanoma Institute Australia, Carole Renouf, said the support from Wyong Rugby League Club Group was particularly relevant given the region had been identified as a melanoma hotspot.
“Wyong and the Central Coast are among 28 melanoma hotspots around the state, meaning they have some of the highest rates of melanoma, significantly above the state average,” Ms Renouf said.
“Melanoma is the most common cancer affecting Australians aged 15-39 and kills more 20-39 year olds than any other single cancer. Incidence in the over the 60s is also increasing.
“The support from Wyong Rugby League Club Group means we are equipped with the latest equipment and technology to ensure melanoma patients, many of whom come from the Wyong and Central Coast areas, receive the best possible treatment,” she said.
CEO of Wyong Rugby League Club Group, Michael Coghlan, said with seven venues located on the Central Coast and 50,000 members, it had always been a core focus of the group to support local organisations, sporting groups and the greater community. “We recognise that the Central Coast is a melanoma hotspot and we look forward to growing our partnership and raising awareness with Melanoma Institute Australia,” he said.
The partnership between MIA and Wyong Rugby League Club Group also extends to support of The Longest Melanoma March, a 1200 kilometre trek from Brisbane to Sydney by MIA Community Coordinator and melanoma survivor Jay Allen. Wyong Rugby League Club Group hosted a range of fundraising activities at the Bateau Bay Bowling Club today to welcome Jay as he walked through the Central Coast.
"We sincerely thank Wyong Rugby League Club Group for this generous support,” Ms Renouf said. “It will help us raise awareness about sun-smart behaviour to reduce melanoma risk, and will also assist us in raising vital funds for ongoing research into melanoma prevention and treatment,” she said.
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.